Pepper; Chris
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pepper; Chris.The latest application filed is for "cancer treatments based on gemcitabine prodrugs".
- Pepper; Chris - Cardiff GB
- Pepper; Chris - Penarth GB
- Pepper; Chris - Vale of Glamorgan GB
| Patent | Date |
|---|---|
| Cancer treatments Grant 11,400,107 - Griffith , et al. August 2, 2 | 2022-08-02 |
| Cancer Grant 11,287,416 - Greenfield , et al. March 29, 2 | 2022-03-29 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20210100825 - Griffith; Hugh ; et al. | 2021-04-08 |
| Prognostic mean telomere length Grant 10,724,104 - Baird , et al. | 2020-07-28 |
| Cancer Treatments App 20190374564 - Griffith; Hugh ; et al. | 2019-12-12 |
| Prognostic Mean Telomere Length App 20190276898 - Baird; Duncan ; et al. | 2019-09-12 |
| Prognostic mean telomere length Grant 10,378,065 - Baird , et al. A | 2019-08-13 |
| Cancer App 20190025289 - GREENFIELD; Susan ; et al. | 2019-01-24 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20180289733 - Griffith; Hugh ; et al. | 2018-10-11 |
| Prognostic Mean Telomere Length App 20170137893 - Baird; Duncan ; et al. | 2017-05-18 |
| Prognostic Methodology App 20150292021 - Baird; Duncan ; et al. | 2015-10-15 |
| Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine Grant 8,034,808 - Delavault , et al. October 11, 2 | 2011-10-11 |
| Chronic lymphocytic leukaemia Grant 7,709,199 - Pepper , et al. May 4, 2 | 2010-05-04 |
| Chronic lymphocytic leukaemia App 20080026383 - Pepper; Chris ; et al. | 2008-01-31 |
| Therapeutic Compositions Containing at Least one Pyrrolobenzodiazepine Derivative and Fludarabine App 20070232592 - Delavault; Patrick ; et al. | 2007-10-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 